IP Library Assignment 029121/0736
Patent Assignment
Reel/Frame 029121/0736

Assignment of Assignor's Interest

Recorded: 2012-10-09 Pages: 7
Assignors
MCKINNEY, ANTHONY
Executed: 2008-02-04
TOLLEFSON, GARY
Executed: 2008-02-04
WEBER, ECKARD
Executed: 2008-02-04
SOLTERO, RICK
Executed: 2008-01-02
Assignee
OREXIGEN THERAPEUTICS, INC.
12481 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO, CALIFORNIA, 92130
Covered Property (1)
Layered Pharmaceutical Formulations
Patent: 8,318,788 →
Application: 13/330,395 →
Publication: US 2012/0093889
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement Mar 21, 2016
From: OREXIGEN THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 038180/0021 →
Assignment of Assignor's Interest Aug 2, 2018
From: OREXIGEN THERAPEUTICS, INC.
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 046688/0661 →
Security Interest Aug 6, 2018
From: NALPROPION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 047288/0321 →
Release of Security Interest Sep 27, 2019
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 050574/0106 →
Change of Name Oct 17, 2019
From: NALPROPION PHARMACEUTICALS, INC.
To: NALPROPION PHARMACEUTICALS LLC
Reel/Frame 050750/0497 →
Security Interest Dec 19, 2019
From: CURRAX PHARMACEUTICALS LLC; NALPROPION PHARMACEUTICALS LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 051377/0958 →